000 01419 a2200409 4500
005 20250511191742.0
264 0 _c19920403
008 199204s 0 0 eng d
022 _a0019-9567
024 7 _a10.1128/iai.60.3.853-863.1992
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeno, D W
245 0 0 _aGrowth inhibition of Candida albicans by interleukin-2-activated splenocytes.
_h[electronic resource]
260 _bInfection and immunity
_cMar 1992
300 _a853-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCandida albicans
_xgrowth & development
650 0 4 _aCell Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aInterleukin-2
_xpharmacology
650 0 4 _aKiller Cells, Lymphokine-Activated
_ximmunology
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aLymphocyte Activation
650 0 4 _aLymphocytes
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aRecombinant Proteins
_xpharmacology
650 0 4 _aSpecies Specificity
650 0 4 _aSpleen
_ximmunology
650 0 4 _aTumor Cells, Cultured
700 1 _aMathews, H L
773 0 _tInfection and immunity
_gvol. 60
_gno. 3
_gp. 853-63
856 4 0 _uhttps://doi.org/10.1128/iai.60.3.853-863.1992
_zAvailable from publisher's website
999 _c1548043
_d1548043